712 related articles for article (PubMed ID: 1677361)
1. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.
Lima L; Arce V; Diaz MJ; Tresguerres JA; Devesa J
J Clin Endocrinol Metab; 1993 Feb; 76(2):439-44. PubMed ID: 8094392
[TBL] [Abstract][Full Text] [Related]
3. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
5. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
[TBL] [Abstract][Full Text] [Related]
6. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Cordido F; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
[TBL] [Abstract][Full Text] [Related]
7. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
Peñalva A; Burguera B; Casabiell X; Tresguerres JA; Dieguez C; Casanueva FF
Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
[TBL] [Abstract][Full Text] [Related]
8. Regulation of hypothalamic somatostatin by glucocorticoids.
Devesa J; Barros MG; Gondar M; Tresguerres JA; Arce V
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):277-82. PubMed ID: 7626468
[TBL] [Abstract][Full Text] [Related]
9. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects.
Peñalva A; Muruais C; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1990 Feb; 70(2):324-7. PubMed ID: 2105328
[TBL] [Abstract][Full Text] [Related]
10. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
[TBL] [Abstract][Full Text] [Related]
11. Influence of endogenous cholinergic tone and alpha-adrenergic pathways on growth hormone responses to His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the dog.
Muruais J; Peñalva A; Dieguez C; Casanueva FF
J Endocrinol; 1993 Aug; 138(2):211-8. PubMed ID: 8228729
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological manipulations of alpha-adrenoceptors in the infant rat and effects on growth hormone secretion. Study of the underlying mechanisms of action.
Cella SG; Locatelli V; De Gennaro V; Wehrenberg WB; Müller EE
Endocrinology; 1987 Apr; 120(4):1639-43. PubMed ID: 2881775
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
Giusti M; Marini G; Sessarego P; Peluffo F; Valenti S; Caratti C; Giordano G
Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302
[TBL] [Abstract][Full Text] [Related]
14. Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone.
Valcavi R; Zini M; Maestroni GJ; Conti A; Portioli I
Clin Endocrinol (Oxf); 1993 Aug; 39(2):193-9. PubMed ID: 8370132
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
Ismail IS; Scanlon MF; Peters JR
Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
[TBL] [Abstract][Full Text] [Related]
16. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
[TBL] [Abstract][Full Text] [Related]
17. Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine.
Ghigo E; Arvat E; Nicolosi M; Mazza E; Camanni F
Panminerva Med; 1990; 32(1):1-3. PubMed ID: 2263395
[TBL] [Abstract][Full Text] [Related]
18. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep.
Magnan E; Cataldi M; Guillaume V; Mazzocchi L; Dutour A; Razafindraibe H; Sauze N; Renard M; Oliver C
Endocrinology; 1994 Feb; 134(2):562-7. PubMed ID: 7905408
[TBL] [Abstract][Full Text] [Related]
19. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
Mota A; Bento A; Peñalva A; Pombo M; Dieguez C
J Clin Endocrinol Metab; 1995 Jun; 80(6):1973-7. PubMed ID: 7775648
[TBL] [Abstract][Full Text] [Related]
20. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
Jaffe CA; DeMott-Friberg R; Barkan AL
J Clin Invest; 1996 Feb; 97(4):934-40. PubMed ID: 8613546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
